HRP20020716A2 - Breast cancer hormonal therapy - Google Patents

Breast cancer hormonal therapy Download PDF

Info

Publication number
HRP20020716A2
HRP20020716A2 HR20020716A HRP20020716A HRP20020716A2 HR P20020716 A2 HRP20020716 A2 HR P20020716A2 HR 20020716 A HR20020716 A HR 20020716A HR P20020716 A HRP20020716 A HR P20020716A HR P20020716 A2 HRP20020716 A2 HR P20020716A2
Authority
HR
Croatia
Prior art keywords
exemestane
treatment
choice
breast cancer
amount
Prior art date
Application number
HR20020716A
Other languages
English (en)
Croatian (hr)
Inventor
Giorgio Massimini
Robert Paridaens
Jean-Pierre Lobelle
Gabriella Piscitelli
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of HRP20020716A2 publication Critical patent/HRP20020716A2/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HR20020716A 2000-03-03 2001-02-20 Breast cancer hormonal therapy HRP20020716A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0005257.1A GB0005257D0 (en) 2000-03-03 2000-03-03 Breast cancer hormonal therapy

Publications (1)

Publication Number Publication Date
HRP20020716A2 true HRP20020716A2 (en) 2003-12-31

Family

ID=9886975

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020716A HRP20020716A2 (en) 2000-03-03 2001-02-20 Breast cancer hormonal therapy

Country Status (21)

Country Link
US (1) US20030144259A1 (pl)
EP (1) EP1530478A2 (pl)
JP (1) JP2003525233A (pl)
KR (1) KR20020084167A (pl)
CN (1) CN1213755C (pl)
AU (1) AU2001254652A1 (pl)
BR (1) BR0108951A (pl)
CA (1) CA2401041A1 (pl)
CZ (1) CZ20022981A3 (pl)
EA (1) EA005413B1 (pl)
EE (1) EE200200479A (pl)
GB (1) GB0005257D0 (pl)
HR (1) HRP20020716A2 (pl)
HU (1) HUP0301123A3 (pl)
MX (1) MXPA02008574A (pl)
NO (1) NO20023971L (pl)
NZ (1) NZ521315A (pl)
PL (1) PL358542A1 (pl)
SK (1) SK11902002A3 (pl)
WO (1) WO2001064193A2 (pl)
ZA (1) ZA200207260B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1317270A1 (en) * 2000-09-08 2003-06-11 Pharmacia Italia S.p.A. Exemestane for the treatment of oestrogen-dependent cancers
LT2762140T (lt) 2001-02-19 2017-06-26 Novartis Ag Solidinių smegenų navikų gydymas rapamicino dariniu
DK1624878T3 (da) * 2003-05-22 2007-01-08 Pantarhei Bioscience Bv Anvendelse af præparater som omfatter en östrogen komponent til behandling og forebyggelse af muskel-skelet-smerte
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
DE102006008074B4 (de) * 2006-02-22 2013-08-14 RUHR-UNIVERSITäT BOCHUM Behandlung von Krebs mit Geruchsrezeptor-Liganden
CN101468023B (zh) * 2007-12-26 2011-02-02 上海复星医药（集团）股份有限公司 依西美坦片及其制备工艺
KR200450538Y1 (ko) * 2008-05-29 2010-10-11 최용희 보자기형배낭
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones

Also Published As

Publication number Publication date
EE200200479A (et) 2003-12-15
NZ521315A (en) 2008-10-31
CZ20022981A3 (cs) 2003-02-12
NO20023971D0 (no) 2002-08-21
PL358542A1 (pl) 2004-08-09
HUP0301123A3 (en) 2007-10-29
US20030144259A1 (en) 2003-07-31
WO2001064193A3 (en) 2002-07-25
EP1530478A2 (en) 2005-05-18
CA2401041A1 (en) 2001-09-07
WO2001064193A2 (en) 2001-09-07
CN1213755C (zh) 2005-08-10
EA200200943A1 (ru) 2003-02-27
BR0108951A (pt) 2002-11-26
CN1407896A (zh) 2003-04-02
ZA200207260B (en) 2003-09-10
MXPA02008574A (es) 2003-05-01
AU2001254652A1 (en) 2001-09-12
EA005413B1 (ru) 2005-02-24
HK1053424A1 (en) 2003-10-24
JP2003525233A (ja) 2003-08-26
HUP0301123A2 (hu) 2003-08-28
SK11902002A3 (sk) 2003-05-02
NO20023971L (no) 2002-08-21
GB0005257D0 (en) 2000-04-26
KR20020084167A (ko) 2002-11-04

Similar Documents

Publication Publication Date Title
CA2768882C (en) Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6451779B1 (en) Composition and method for contraception and treatment of tumors of the mammary glands
HUT74575A (en) Methods for preparing pharmaceuticals, suitable for inhibiting bone loss containing, 3,4-diarylchroman
CN1997353A (zh) 用于减轻雌激素替代疗法副作用的药物组合物和方法
US20030144259A1 (en) Breast cancer hormonal therapy
AU2002338277B2 (en) Estrogen replacement therapy
AU2002338277A1 (en) Estrogen replacement therapy
TWI354556B (en) Use of a combination of an aromatase inhibitor,a p
KR19990077157A (ko) 유방암의 치료 또는 예방을 위한 약학적 조성물의 제조를 위한센트크로만의 l－거울상이성질체의 사용
US20060135494A1 (en) Methods of treating injuries of the nervous system associated with hemorrhage
US6245812B1 (en) Treatment of hot flashes (flushing) using leucine alone or in combination with other branched chain amino acids
WO2000069467A1 (en) Combined method of treatment comprising an aromatase inhibitor and a further biologically active compound
EP3923937B1 (en) Combinations of dexamethasone and indomethacin with thiazolidinediones for use in the prevention or treatment of abnormal bone growth
EP1007052A1 (en) Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
US20030158168A1 (en) Composition for combined use of aromatase inhibitors
HK1053424B (en) The use of exemestane for the preparation of a medicament for the first-line treatmentof breast cancer
MX2008000276A (es) Uso de activadores de guanilato ciclasa solubles para el tratamiento contra dano por reperfusion.
KR101742023B1 (ko) 보르테조밉을 유효성분으로 함유하는 담석증의 예방 또는 치료용 약학적 조성물
Inoue et al. Therapeutic Value of Mepitiostane in the Treatment of Advanced Breast
AU7181291A (en) Compositions and methods for alleviating menopausal symptoms
WO2026021460A1 (zh) 治疗前列腺癌的方法
TWI293251B (en) Selective estrogen receptor modulators incombination with estrogens
Nomura et al. Therapeutic Value of Mepitiostane in the Treatment of Advanced Breast
HK1099996A (en) Estrogen replacement therapy

Legal Events

Date Code Title Description
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
A1OB Publication of a patent application
OBST Application withdrawn